In the central nervous system (CNS), the recent literature identified a novel histomolecular type, named “intracranial mesenchymal tumor (IMT), FET-CREB fusion-positive” which will be added in the new WHO classification [1]. This evidence concerns the gene CREB1 and inflammatory myofibroblastic tumor.